R&D Intensity and IPO Underpricing : Case Study on Pharmaceutical and Biotech Industries in the US
Year of publication: |
2018
|
---|---|
Authors: | Efrata, Tommy C. |
Publisher: |
[2018]: [S.l.] : SSRN |
Subject: | USA | United States | Biotechnologie-Industrie | Biotechnology industry | Pharmaindustrie | Pharmaceutical industry | Börsengang | Initial public offering | Industrieforschung | Industrial research | Emissionskurs | Offering price |
Extent: | 1 Online-Ressource (21 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Jurnal Akuntansi dan Investasi (Accounting and Investment Journal) Vol. 9 No. 1, pp: 1-21, January 2008 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments June 30, 2008 erstellt |
Classification: | G11 - Portfolio Choice ; G14 - Information and Market Efficiency; Event Studies ; G15 - International Financial Markets |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Comparative Analysis of Underpricing and Subscription of SME IPOs and Main Board IPOs in India
Sharma, Sudesh Kumar, (2020)
-
Genovevo da Costa, Marcio, (2016)
-
Does Grading of IPOs Improve Demand and Underpricing?
Sharma, Sudesh Kumar, (2013)
- More ...
-
Identification of Innovation Process on New Product Development in Small and Medium Enterprises
Efrata, Tommy C., (2020)
-
Efrata, Tommy C., (2016)
-
Efrata, Tommy C., (2022)
- More ...